Thermo fisher scientific and sanofi expand strategic partnership to enable additional u.s. drug product manufacturing

Waltham, mass.--(business wire)--thermo fisher scientific inc. (nyse:tmo), the world leader in serving science, today announced an expansion of their strategic partnership with sanofi to enable additional u.s. drug product manufacturing. the terms of the deal were not disclosed. under the agreement, thermo fisher will acquire sanofi's steriles manufacturing site in ridgefield, new jersey and will continue to manufacture a portfolio of therapies for sanofi. in addition, thermo fisher will expand.
TMO Ratings Summary
TMO Quant Ranking